Krystal Biotech, Inc. (KRYS) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Krystal Biotech, Inc. (KRYS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.21B, listed on NASDAQ, employing roughly 275 people, carrying a beta of 0.49 to the broader market. Krystal Biotech, Inc. Led by Krish S. Krishnan, public since 2017-09-20.
Snapshot as of May 14, 2026.
- Spot Price
- $315.13
- Total OI
- 6.7K
Learn how max pain is reported and how to read the data →
KRYS highest open-interest contracts
| Type | Strike | Expiration | Volume | OI | IV | Bid | Ask |
|---|---|---|---|---|---|---|---|
| CALL | $310.00 | Jun 18, 2026 | 1 | 787 | 37.6% | $12.50 | $15.70 |
| CALL | $320.00 | Aug 21, 2026 | 0 | 762 | 43.8% | $22.80 | $26.50 |
Top 2 contracts from the ORATS-sourced nightly scan; ranked by oi within the broader S&P 500/400/600 + ETF universe.